✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Welcure Drugs & Pharmaceuticals Ltd.

WELCURE

Market Cap
₹153 Cr.
P/E
70.39

Welcure Drugs & Pharmaceuticals Ltd.

  • Welcure Drugs&Pharma
  • IFL Enterprises
  • Bizotic Commercial
FAQs on Welcure Drugs & Pharmaceuticals Ltd. Shareprice

Welcure Drugs&Pharma has given better returns compared to its competitors.
Welcure Drugs&Pharma has grown at ~173.09% over the last 1yrs while peers have grown at a median rate of -22.36%

Welcure Drugs&Pharma is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Welcure Drugs&Pharma is 70.39, while 3 year average PE is 152.
Also latest EV/EBITDA of Welcure Drugs&Pharma is 90.34 while 3yr average is 90.01.

View FAQ's On Business
Growth Table
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Balance Sheet
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Cash Flow
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Quarterly Results
  • Welcure Drugs & Pharmaceuticals Ltd.
  • IFL Enterprises
  • Bizotic Commercial
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Welcure Drugs & Pharmaceuticals Ltd. Financials

Welcure Drugs&Pharma balance sheet is weak and might have solvency issues

Yes, The net debt of Welcure Drugs&Pharma is increasing.
Latest net debt of Welcure Drugs&Pharma is ₹123 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹0.04 Crs.

The profit is oscillating.
The profit of Welcure Drugs&Pharma is ₹4.45 Crs for TTM, -₹0.17 Crs for Mar 2024 and ₹0.1 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Welcure Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech